
Sign up to save your podcasts
Or


Chief Cross-Asset Strategist Andrew Sheets continues his conversation with Biotech Equity Analyst Matt Harrison on COVID-19 variants and the future of the health care industry.
By Morgan Stanley4.8
12461,246 ratings
Chief Cross-Asset Strategist Andrew Sheets continues his conversation with Biotech Equity Analyst Matt Harrison on COVID-19 variants and the future of the health care industry.

1,715 Listeners

977 Listeners

406 Listeners

1,173 Listeners

2,175 Listeners

198 Listeners

686 Listeners

1,044 Listeners

191 Listeners

70 Listeners

80 Listeners

1,574 Listeners

436 Listeners

212 Listeners

118 Listeners

81 Listeners

0 Listeners